Amgen

We track 10 ClinicalTrials.gov studies led by Amgen. The portfolio skews toward Phase 3 (5 trials).

10 clinical trials sponsored by Amgen.

Pipeline by Phase

PhaseTrialsDistribution
Phase 3 5
50%
Phase 2 3
30%
N/A 1
10%
Phase 1 1
10%

Trial Status Breakdown

Trials by Amgen

A Phase 3, Open Label, Multicenter, Randomized Study of First Line Tarlatamab in Combination With Durvalumab, Carboplatin and Etoposide Versus Durvalumab, Carboplatin and Etoposide in Untreated Extensive Stage Small-Cell Lung Cancer (DeLLphi-312)

NCT07005128 · RECRUITING · Phase 3

Real World Evaluation of Sotorasib Among Chinese Non-Small Cell Lung Cancer Patients

NCT07143513 · COMPLETED · N/A

A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

NCT07037433 · RECRUITING · Phase 3

A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Maridebart Cafraglutide on Mortality and Morbidity in Participants Living With Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF)

NCT07037459 · RECRUITING · Phase 3

A Multicenter, Open-Label, Long-term, Extension Study to Evaluate the Safety and Tolerability of Dazodalibep in Participants With Sjögren's Syndrome (SS)

NCT06747949 · RECRUITING · Phase 3

A Randomized, Double-blind, Parallel-group Study to Compare Pharmacokinetics, Pharmacodynamics, Clinical Effects, and Safety Between ABP 692 and Ocrevus® (Ocrelizumab) in Subjects With Relapsing-remitting Multiple Sclerosis

NCT06700343 · RECRUITING · Phase 3

A Phase 2 Study Evaluating the Efficacy, Safety, Tolerability, and Pharmacokinetics of Anvumetostat in Subjects With Methylthioadenosine Phosphorylase (MTAP)-Deleted Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC)

NCT06593522 · RECRUITING · Phase 2

A Phase 1b Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Anvumetostat Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol)

NCT06333951 · RECRUITING · Phase 1

A Phase 1/2 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Anvumetostat in Combination With IDE397 in Subjects With Advanced MTAP-null Solid Tumors

NCT05975073 · ACTIVE NOT RECRUITING · Phase 2

A Phase 1/1b/2 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Anvumetostat Alone and in Combination With Docetaxel in Subjects With Advanced MTAP-null Solid Tumors

NCT05094336 · ACTIVE NOT RECRUITING · Phase 2

Frequently Asked Questions

How many clinical trials does Amgen sponsor?

Amgen currently sponsors 10 clinical trials tracked on ReadTheTrial. These span Phase 3, Phase 2, N/A, Phase 1.

What conditions does Amgen research?

Amgen conducts research across multiple therapeutic areas. Browse the trial listings for details.

Is Amgen recruiting for clinical trials?

Yes, Amgen currently has 7 trials that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.

Explore More